Overview

Major advances have been made in the understanding of the molecular mechanisms of atherosclerosis, the disease that still affects more than 50 percent of the population in the highly industrialized countries. This volume covers the most recent advances in the treatment of hyperlipidemia. It represents a necessary update because molecular mechanisms of atherogenesis have been discovered in the past few years and their molecular mechanisms of action identified. Extensively treated are the molecular mechanisms of disease etiology of arteriosclerosis in relation to the major risk factor ""hyperlipidemia"", rationale for more effective treatment of this disease by dietary means, the treatment of associated or causing diseases, and the treatment using hypolipidemic drugs.

Full Product Details

Author:   Gotthard Schettler ,  D.H. Blankenhorn ,  Andreas J.R. Habenicht ,  H.B. Brewer
Publisher:   Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Imprint:   Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Edition:   Softcover reprint of the original 1st ed. 1994
Volume:   109
Dimensions:   Width: 15.50cm , Height: 2.70cm , Length: 23.50cm
Weight:   0.791kg
ISBN:  

9783642784286

ISBN 10:   3642784283
Pages:   502
Publication Date:   16 December 2011
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Section A: Physiology and Pathophysiology of Lipid Metabolism.- 1 An Introduction to the Biochemistry and Biology of Blood Lipids and Lipoproteins.- 2 Lipoprotein Metabolism.- 3 Lipoprotein Receptors.- 4 Genetic Disorders of Lipoprotein Metabolism.- 5 Interactions Between Lipoproteins and the Arterial Wall.- 6 Lipoprotein Lipase and Hepatic Lipase.- 7 Animal Models of Lipoprotein Metabolism.- Section B: Lipid Lowering Therapy.- 8 Rationale to Treat.- 9 The Dietary Therapy of Hyperlipidemia: Its Important Role in the Prevention of Coronary Heart Disease.- 10 Lipid Apheresis.- Section C: Lipid Lowering Drugs.- 11 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors.- 12 Fibrates.- 13 Nicotinic Acid and Derivatives.- 14 Ion Exchange Resins.- 15 Probucol.- 16 Miscellaneous Lipid-Lowering Drugs.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions